Dabigatran Compared With Warfarin for Stroke Prevention With Atrial Fibrillation: Experience in Hong Kong

BACKGROUND: Dabigatran is an oral direct thrombin inhibitor recently approved for stroke prevention in atrial fibrillation (AF) as an alternative to warfarin. The primary advantages of dabigatran are freedom from monitoring and less interaction with other drugs and food. It is ideal for patients who...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Cardiol
Egile Nagusiak: Ho, Jason C. S., Chang, Andy M., Yan, Bryan P., Yu, Cheuk Man, Lam, Yat Yin, Lee, Vivian W. Y.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wiley Periodicals, Inc. 2012
Gaiak:
Clinical Investigations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6652425/
https://ncbi.nlm.nih.gov/pubmed/23108916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22069
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak